FIRST LINE PLATINUM CHEMOTHERAPY

Clinical trials for FIRST LINE PLATINUM CHEMOTHERAPY explained in plain language.

Never miss a new study

Get alerted when new FIRST LINE PLATINUM CHEMOTHERAPY trials appear

Sign up with your email to follow new studies for FIRST LINE PLATINUM CHEMOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope to delay ovarian Cancer's return in High-Risk patients

Disease control Ongoing

This large, late-stage trial is testing whether a drug called olaparib can help keep advanced ovarian cancer from coming back after initial chemotherapy. It is for women with a specific genetic change (BRCA mutation) whose cancer responded well to first treatment. The study compa…

Matched conditions: FIRST LINE PLATINUM CHEMOTHERAPY

Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

FIRST LINE PLATINUM CHEMOTHERAPY

Get alerted when new FIRST LINE PLATINUM CHEMOTHERAPY trials appear

New hope to delay ovarian Cancer's return in High-Risk patients